CHOP’s Center for Childhood Cancer Research (CCCR), has begun a unique collaboration that will contribute to scientific understanding of how immunotherapy can improve the survival of children with B cell acute lymphoblastic leukemia (B-ALL) that resists standard therapy.
Tag Archive: CTL019
Permanent link to this article: http://www.research.chop.edu/blog/blocking-paths-resistance-t-cell-therapy-b/
Dec 13 2012
Permanent link to this article: http://www.research.chop.edu/blog/fire-with-fire/
Dec 09 2012
Cancer therapy for children has come a long way over the last several decades, and the cure rate for some forms of pediatric cancer is at an all-time high. Although this success rate offers tremendous hope and optimism, there are some children whose disease fails to respond to conventional treatment, leaving doctors to explore novel …
Permanent link to this article: http://www.research.chop.edu/blog/leukemia-patient-cancer-free-after-novel-treatment-with-engineered-immune-cells/